NCT00381433View on ClinicalTrials.gov

Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

June 30, 2009

Conditions
Encephalitis
Interventions
DRUG

AVI-4065 Injection

Trial Locations (1)

98418

NW Kinetics, Tacoma

All Listed Sponsors
lead

Sarepta Therapeutics, Inc.

INDUSTRY

NCT00381433 - Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid | Biotech Hunter | Biotech Hunter